Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: The FOCUS-CCTRN Trial

Study Questions:

What is the effect of bone marrow mononuclear cell (BMC) administration through transendocardial injections on myocardial perfusion, left ventricular end-systolic volume (LVESV), and maximal oxygen consumption in patients with coronary artery disease or LV dysfunction, and limiting heart failure or angina?